Biotricity, Inc. (BTCY)

Market Cap	10.29M
Revenue (ttm)	13.27M
Net Income (ttm)	-14.32M
Shares Out	26.73M
EPS (ttm)	-0.83
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	12,720
Average Volume	36,764
Open	0.4260
Previous Close	0.3850
Day's Range	0.3950 - 0.4260
52-Week Range	0.1860 - 0.9200
Beta	1.23
RSI	49.92
Earnings Date	Jun 27, 2025

About Biotricity

Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions primarily in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood ...

• Industry: Medical Devices
• Sector: Healthcare
• CEO: Waqaas Al-Siddiq
• Employees: 55
• Stock Exchange: OTCMKTS
• Ticker Symbol: BTCY

Financial Performance

In 2023, Biotricity's revenue was $12.06 million, an increase of 25.15% compared to the previous year's $9.64 million. Losses were -$14.93 million, -23.57% less than in 2022.